RATIONALE: The chemokine receptor Ccr6 is a G-protein-coupled receptor expressed on various types of leukocytes identified in mouse atherosclerotic lesions. Recent evidence suggests that both CCR6 and its ligand CCL20 are also present in human atheroma; however, their functional roles in atherogenesis remain undefined. OBJECTIVE: Our objective was to delineate the role of Ccr6 in atherogenesis in the apolipoprotein E-deficient (ApoE(-/-)) mouse model of atherosclerosis. METHODS AND RESULTS: Both Ccr6 and Ccl20 are expressed in atherosclerotic aorta from ApoE(-/-) mice. Aortic lesion area in Ccr6(-/-)ApoE(-/-) mice was ∼40% and ∼30% smaller than in Ccr6(+/+)ApoE(-/-) mice at 16 and 24 weeks of age, respectively. Transplantation of bone marrow from Ccr6(-/-) mice into ApoE(-/-) mice resulted in ∼40% less atherosclerotic lesion area than for bone marrow from Ccr6(+/+) mice; lesions in Ccr6(-/-)ApoE(-/-) mice had 44% less macrophage content than lesions in Ccr6(+/+)ApoE(-/-) mice. Ccr6 was expressed on a subset of primary mouse monocytes. Accordingly, Ccl20 induced chemotaxis of primary monocytes from wild-type but not Ccr6(-/-) mice; moreover, Ccl20 induced monocytosis in ApoE(-/-) mice in vivo. Consistent with this, we observed 30% fewer monocytes in circulating blood of Ccr6(-/-)ApoE(-/-) mice, mainly because of fewer CD11b(+)Ly6C(high) inflammatory monocytes. CONCLUSIONS: Ccr6 promotes atherosclerosis in ApoE-deficient mice, which may be due in part to Ccr6 support of normal monocyte levels in blood, as well as direct Ccr6-dependent monocyte migration.
RATIONALE: The chemokine receptor Ccr6 is a G-protein-coupled receptor expressed on various types of leukocytes identified in mouseatherosclerotic lesions. Recent evidence suggests that both CCR6 and its ligand CCL20 are also present in humanatheroma; however, their functional roles in atherogenesis remain undefined. OBJECTIVE: Our objective was to delineate the role of Ccr6 in atherogenesis in the apolipoprotein E-deficient (ApoE(-/-)) mouse model of atherosclerosis. METHODS AND RESULTS: Both Ccr6 and Ccl20 are expressed in atherosclerotic aorta from ApoE(-/-) mice. Aortic lesion area in Ccr6(-/-)ApoE(-/-) mice was ∼40% and ∼30% smaller than in Ccr6(+/+)ApoE(-/-) mice at 16 and 24 weeks of age, respectively. Transplantation of bone marrow from Ccr6(-/-) mice into ApoE(-/-) mice resulted in ∼40% less atherosclerotic lesion area than for bone marrow from Ccr6(+/+) mice; lesions in Ccr6(-/-)ApoE(-/-) mice had 44% less macrophage content than lesions in Ccr6(+/+)ApoE(-/-) mice. Ccr6 was expressed on a subset of primary mouse monocytes. Accordingly, Ccl20 induced chemotaxis of primary monocytes from wild-type but not Ccr6(-/-) mice; moreover, Ccl20 induced monocytosis in ApoE(-/-) mice in vivo. Consistent with this, we observed 30% fewer monocytes in circulating blood of Ccr6(-/-)ApoE(-/-) mice, mainly because of fewer CD11b(+)Ly6C(high) inflammatory monocytes. CONCLUSIONS:Ccr6 promotes atherosclerosis in ApoE-deficient mice, which may be due in part to Ccr6 support of normal monocyte levels in blood, as well as direct Ccr6-dependent monocyte migration.
Authors: Michael N Hedrick; Anke S Lonsdorf; Aiko-Konno Shirakawa; Chyi-Chia Richard Lee; Fang Liao; Satya P Singh; Hongwei H Zhang; Alexander Grinberg; Paul E Love; Sam T Hwang; Joshua M Farber Journal: J Clin Invest Date: 2009-08 Impact factor: 14.808
Authors: Filip K Swirski; Matthias Nahrendorf; Martin Etzrodt; Moritz Wildgruber; Virna Cortez-Retamozo; Peter Panizzi; Jose-Luiz Figueiredo; Rainer H Kohler; Aleksey Chudnovskiy; Peter Waterman; Elena Aikawa; Thorsten R Mempel; Peter Libby; Ralph Weissleder; Mikael J Pittet Journal: Science Date: 2009-07-31 Impact factor: 47.728
Authors: Chiara Giannarelli; David T Rodriguez; M Urooj Zafar; Daniel Christoffel; Vincent Vialou; Catherine Peña; Ana Badimon; Georgia F Hodes; Pauline Mury; Jacklyn Rabkin; Matilde Alique; Giulia Villa; Carmen Argmann; Eric J Nestler; Scott J Russo; Juan J Badimon Journal: Thromb Haemost Date: 2017-01-12 Impact factor: 5.249
Authors: Wuzhou Wan; Qian Liu; Michail S Lionakis; Ana Paula M P Marino; Stasia A Anderson; Muthulekha Swamydas; Philip M Murphy Journal: Cardiovasc Res Date: 2015-04-08 Impact factor: 10.787
Authors: Amanda C Doran; Michael J Lipinski; Stephanie N Oldham; James C Garmey; Kirsti A Campbell; Marcus D Skaflen; Alexis Cutchins; Daniel J Lee; David K Glover; Kimberly A Kelly; Elena V Galkina; Klaus Ley; Joseph L Witztum; Sotirios Tsimikas; Timothy P Bender; Coleen A McNamara Journal: Circ Res Date: 2011-10-27 Impact factor: 17.367
Authors: Bisweswar Nandi; Mia Shapiro; Mehmet K Samur; Christine Pai; Natasha Y Frank; Charles Yoon; Rao H Prabhala; Nikhil C Munshi; Jason S Gold Journal: Oncoimmunology Date: 2016-05-24 Impact factor: 8.110
Authors: Michael J Lipinski; Kirsti A Campbell; Son Q Duong; Thomas J Welch; James C Garmey; Amanda C Doran; Marcus D Skaflen; Stephanie N Oldham; Kimberly A Kelly; Coleen A McNamara Journal: Arterioscler Thromb Vasc Biol Date: 2012-10-04 Impact factor: 8.311